Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State

Journal of Clinical Microbiology
Jeffrey M SchapiroAjit P Limaye

Abstract

Members of the Bacteroides fragilis group are among the most common anaerobic bacterial isolates in clinical specimens. Metronidazole, a 5-nitroimidazole, is often used as empirical therapy for anaerobic infections. Susceptibility testing is not routinely performed because of nearly universal susceptibility of Bacteroides spp. to this agent. We report a case of metronidazole-resistant Bacteroides fragilis in the United States and demonstrate the presence of the nimA gene, encoding a nitroreductase previously shown to mediate resistance to 5-nitroimidazole antimicrobial agents in B. fragilis strains from Europe and Africa. Because clinical failures in Bacteroides infections have been associated with the use of inactive antimicrobial agents, clinicians need to be aware of the possibility of metronidazole-resistant B. fragilis strains in the United States and the importance of susceptibility testing in selected situations.

References

Jul 1, 1979·Antimicrobial Agents and Chemotherapy·M L Britz, R G Wilkinson
Jul 1, 1991·The Journal of Antimicrobial Chemotherapy·S NarikawaM Nakamura
Jan 1, 1990·Scandinavian Journal of Infectious Diseases·J BreuilC Burnat
Jun 1, 1986·European Journal of Clinical Microbiology·A DublanchetH B Drugeon
Dec 1, 1983·The Journal of Infectious Diseases·J S SigetiC E Davis
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M C RedondoD R Snydman
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W HechtJ P O'Keefe
Sep 1, 1996·Journal of Clinical Microbiology·S Trinh, G Reysset
Dec 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D R SnydmanS L Gorbach
Jul 1, 1997·Antimicrobial Agents and Chemotherapy·J P CarlierG Reysset
Oct 6, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R S RomanL E Nicolle
Feb 12, 1998·Nucleic Acids Research·B B RosenblumS M Chen
Mar 18, 1999·FEMS Microbiology Letters·M M LubbeL J Chalkley
Jun 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H NguyenD R Snydman
Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A DeplanoM J Struelens
May 15, 2002·International Journal of Antimicrobial Agents·Hong FangCarl Erik Nord
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D R SnydmanS L Gorbach

❮ Previous
Next ❯

Citations

Jan 5, 2006·Current Microbiology·Jessica Manya B D VieiraMaria Candida de S Ferreira
Feb 2, 2006·Current Microbiology·Manfred FilleReiner Schaumann
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Sonja LöfmarkCharlotta Edlund
Oct 16, 2007·Clinical Microbiology Reviews·Hannah M Wexler
Jan 9, 2014·PloS One·Patrick M ChongUNKNOWN Canadian Nosocomial Infection Surveillance Program (CNISP)
Mar 13, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·José MolinaEvelyn Rodríguez-Cavallini
Jul 5, 2013·Clinical Microbiology Reviews·Itzhak BrookEllie J C Goldstein
Apr 22, 2006·Diagnostic Microbiology and Infectious Disease·Anastasia KatsandriUNKNOWN Hellenic Study Group for Gram-Negative Anaerobic Bacteria
Mar 22, 2008·FEMS Microbiology Reviews·María Dolores RoldánConrado Moreno-Vivián
Nov 20, 2012·International Journal of Antimicrobial Agents·József SókiUNKNOWN ESCMID Study Group on Anaerobic Infections
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L PumbweH M Wexler
Nov 5, 2016·Anaerobe·Christine J HasteyUNKNOWN From the Ad Hoc Working Group on Antimicrobial Susceptibility Testing of Anaerobic Bacteria of CLSI
Aug 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fanny MathiasPatrice Vanelle
Dec 9, 2017·Frontiers in Microbiology·Mehrdad Tajkarimi, Hannah M Wexler
Jun 14, 2005·The Journal of Antimicrobial Chemotherapy·C BetriuJ J Picazo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
V O RotimiF.B. Khodakhast
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Maria HedbergESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria
The Journal of Antimicrobial Chemotherapy
Claudio Galuppo DinizC J Smith
© 2021 Meta ULC. All rights reserved